N4 Pharma (LON:N4P) Stock Price Down 7.1% – Time to Sell?

N4 Pharma Plc (LON:N4P)’s stock price dropped 7.1% during trading on Thursday . The stock traded as low as GBX 0.65 ($0.01) and last traded at GBX 0.70 ($0.01). Approximately 13,901,041 shares changed hands during trading, an increase of 197% from the average daily volume of 4,678,713 shares. The stock had previously closed at GBX 0.75 ($0.01).

N4 Pharma Stock Down 0.7 %

The company has a current ratio of 22.73, a quick ratio of 7.28 and a debt-to-equity ratio of 1.62. The company has a 50-day simple moving average of GBX 0.62 and a 200 day simple moving average of GBX 0.58. The company has a market cap of £2.65 million, a P/E ratio of -55.00 and a beta of -0.37.

About N4 Pharma

N4 Pharma is a specialist pharmaceutical company developing novel delivery systems for oncology, gene therapy and vaccines It has a unique silica nanoparticle delivery system called Nuvec® and another unique peptide.lipid system called Liptide® which it operates through its subsidiary Nanogenics Ltd

N4 Pharma’s business model is to partner with companies developing novel antigens in these fields to use Nuvec® as the delivery vehicle for these antigens.